Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Israel Journal of Health Policy Research
Published in: Israel Journal of Health Policy Research 1/2012

Open Access 01-12-2012 | Commentary

Improving health outcomes: innovation, coverage, quality and adherence

Authors: Martin McKee, Clara K Chow

Published in: Israel Journal of Health Policy Research | Issue 1/2012

Login to get access

Abstract

The Israeli health system has made considerable progress in reducing deaths amenable to medical care but has more to do. This commentary describes how progress in this area results from innovation, coverage, quality, and adherence to treatment. It describes what is being done in Israel and beyond to address each of these factors but concentrates on the often poorly recognised problem of adherence to treatment, describing the growing evidence that it is often sub-optimal and reviewing evidence on what can be done to improve it.
Literature
1.
Goldberger N, Haklai Z: Mortality rates in Israel from causes amenable to health care, regional and international comparison. Isr J Health Policy Res. 2012, 1 (1): 41-10.1186/2045-4015-1-41.PubMedCentralCrossRefPubMed
2.
Nolte E, McKee CM: In Amenable Mortality–Deaths Avoidable Through Health Care–Progress In The US Lags That Of Three European Countries. Health Aff (Millwood). 2012, 31 (9): 2114-22. 10.1377/hlthaff.2011.0851.CrossRef
3.
Litwin H, Sapir EV: Forgone health care due to cost among older adults in European countries and in Israel. Eur J Ageing. 2009, 2009 (6): 167-176.CrossRef
4.
Lecky F, Woodford M, Yates DW: Trends in trauma care in England and Wales 1989–97. UK Trauma Audit and Research Network. Lancet. 2000, 355 (9217): 1771-5. 10.1016/S0140-6736(00)02264-9.CrossRefPubMed
5.
Toren O, et al: Turnover of registered nurses in Israel: characteristics and predictors. Health Policy. 2012, 105 (2–3): 203-13.CrossRefPubMed
6.
Nissanholtz-Gannot R, Rosen B, T. Quality Monitoring Study Group, Monitoring quality in Israeli primary care: The primary care physicians' perspective. Isr J Health Policy Res. 2012, 1 (1): 26-10.1186/2045-4015-1-26.PubMedCentralCrossRefPubMed
7.
Rosen B, et al: What the United States could learn from Israel about improving the quality of health care. Health Aff (Millwood). 2011, 30 (4): 764-72. 10.1377/hlthaff.2011.0061.CrossRef
8.
Ayalon L, et al: Disparities in antidepressant adherence in primary care: report from Israel. Am J Manag Care. 2011, 17 (9): e340-7.PubMed
9.
Gadkari AS, McHorney CA: Medication nonfulfillment rates and reasons: narrative systematic review. Curr Med Res Opin. 2010, 26 (3): 683-705. 10.1185/03007990903550586.CrossRefPubMed
10.
Chapman RH, et al: Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005, 165 (10): 1147-52. 10.1001/archinte.165.10.1147.CrossRefPubMed
11.
Goldberg AI, Cohen G, Rubin AH: Physician assessments of patient compliance with medical treatment. Soc Sci Med. 1998, 47 (11): 1873-6. 10.1016/S0277-9536(98)00259-7.CrossRefPubMed
12.
Lapane KL, et al: Misperceptions of patients vs providers regarding medication-related communication issues. Am J Manag Care. 2007, 13 (11): 613-8.PubMed
13.
DiMatteo MR: Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004, 42 (3): 200-9. 10.1097/01.mlr.0000114908.90348.f9.CrossRefPubMed
14.
Bramley TJ, et al: Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006, 12 (3): 239-45.PubMed
15.
Ho PM, et al: Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006, 166 (17): 1842-7. 10.1001/archinte.166.17.1842.CrossRefPubMed
16.
Danchin N, et al: Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry. Am Heart J. 2005, 150 (6): 1147-53. 10.1016/j.ahj.2005.01.058.CrossRefPubMed
17.
Ho PM, et al: Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006, 166 (17): 1836-41. 10.1001/archinte.166.17.1836.CrossRefPubMed
18.
Hershman DL, et al: Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011, 126 (2): 529-37. 10.1007/s10549-010-1132-4.PubMedCentralCrossRefPubMed
19.
Roebuck MC, et al: Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood). 2011, 30 (1): 91-9. 10.1377/hlthaff.2009.1087.CrossRef
20.
Haynes RB, et al: Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008, CD000011, 2
21.
Katzir Z, et al: Medication apprehension and compliance among dialysis patients–a comprehensive guidance attitude. Nephron Clin Pract. 2010, 114 (2): c151-7. 10.1159/000254388.CrossRefPubMed
22.
Shimoni Z, et al: Empowering surgical nurses improves compliance rates for antibiotic prophylaxis after caesarean birth. J Adv Nurs. 2009, 65 (11): 2345-9. 10.1111/j.1365-2648.2009.05096.x.CrossRefPubMed
23.
Piette JD, et al: Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse?. Patient Prefer Adherence. 2011, 5: 187-94.PubMedCentralCrossRefPubMed
24.
Rosen B, Merkur S: Israel: Health system review. Health Systems in Transition. 2009, 11 (2): 1-226.
25.
Elhayany A, Vinker S: Addressing healthcare inequities in Israel by eliminating prescription drug copayments. Am J Manag Care. 2011, 17 (7): e255-9.PubMed
26.
Marshall IJ, Wolfe CD, McKevitt C: Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012, 345: e3953-10.1136/bmj.e3953.PubMedCentralCrossRefPubMed
27.
Ben-Natan M, Noselozich I: Factors affecting older persons' adherence to prescription drugs in Israel. Nurs Health Sci. 2011, 13 (2): 164-9. 10.1111/j.1442-2018.2011.00594.x.CrossRefPubMed
28.
McCartney M: The Patient Paradox: Why sexed-up medicine is bad for your health. 2012, London: Pinter & Martin
29.
Britton A, et al: Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy. 1999, 4 (2): 112-21.PubMed
Metadata
Title
Improving health outcomes: innovation, coverage, quality and adherence
Authors
Martin McKee
Clara K Chow
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Israel Journal of Health Policy Research / Issue 1/2012
Electronic ISSN: 2045-4015
DOI
https://doi.org/10.1186/2045-4015-1-43

Other articles of this Issue 1/2012

Israel Journal of Health Policy Research 1/2012 Go to the issue

Original research article

Medical specialty considerations by medical students early in their clinical experience

Book review

Review essay: politics, power, and universal health care by Stuart Altman and David Schachtman

Commentary

How society treats smoking

Commentary

To see ourselves as others see us

Commentary

A first step in determining appropriate amounts of obstetric anesthesia work

Commentary

Planning and managing the physician workforce